Cybin Inc (CYBN)

[Elite8]

Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “Science Drives Surging Interest in Psychedelic Therapeutics.”

Psilocybins are a hallucinogenic substance found in certain types of mushroom, dubbed magic mushrooms, and used for centuries by indigenous cultures for religious, spiritual and health-related purposes. As is often the case, the modern world is learning from the ancient as mounting evidence points to these prolific fungi as a source for long-sought-for help in mental health and neurological disorders.
Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF ) is intent on becoming the leader in this exciting breakthrough for mental well-being. The company is at the forefront of the revolution in mental health therapeutics and is developing a new class of psychedelic medicines and treatment protocols. Driving its commitment to excellence is the company’s impressive leadership team of experienced professionals with a combined 80-plus years in the pharmaceutical To view the full editorial,
please visit: https://nnw.fm/3IBl7